Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 8/2018

01-08-2018 | Capsule Commentary

Capsule Commentary on Waitzfelder et al., Treatment Initiation for New Episodes of Depression in Primary Care Settings

Author: Hale Thompson, PhD

Published in: Journal of General Internal Medicine | Issue 8/2018

Login to get access

Excerpt

The study by Waitzfelder and colleagues provides a unique opportunity to examine factors associated with initiation of depression treatment in primary care settings across five large integrated health systems in five states.1 Leveraging electronic health record data, the findings mostly confirm documented mental health disparities.2 The odds of engaging in treatment decreased with age and income and for persons of color, who were also more likely than white patients to choose psychotherapy over antidepressant medication. Notably, the odds of initiating treatment were higher for patients who were screened with the Patient Health Questionnaire (PHQ)-9 than for those who were not. …
Literature
1.
2.
3.
Rose G. Rose’s Strategy of Preventive Medicine. Second. Oxford: Oxford University Press; 2008.CrossRef
4.
5.
Metadata
Title
Capsule Commentary on Waitzfelder et al., Treatment Initiation for New Episodes of Depression in Primary Care Settings
Author
Hale Thompson, PhD
Publication date
01-08-2018
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 8/2018
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4319-8

Other articles of this Issue 8/2018

Journal of General Internal Medicine 8/2018 Go to the issue

Capsule Commentary

Capsule Commentary on Lin et. al. Empirical Comparison of Publication Bias Tests in Meta-analysis

Original Research

Impact of Patient-Centered Medical Home Implementation on Diabetes Control in the Veterans Health Administration

Original Research

The Role of Primary Care Experiences in Obtaining Treatment for Depression

Letter to the Editor

Design and Interpretation of Noninferiority Trials

Editorial

“Thinking Time”: Doctor Envies Curlers

Concise Research Reports

Gout and Hypothyroidism in the Elderly: an Observational Cohort Study Using U.S. Medicare Claims Data
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits